Panbela Therapeutics, Inc. Capital Expenditures
Panbela Therapeutics, Inc. reported Capital Expenditures of $5.12 thousand for the 12-month period ending 2013-12-31, per its 10-K filed 2015-03-30.
Discontinued › Cash Flow › Investing Activities
us-gaap:PaymentsToAcquirePropertyPlantAndEquipment · last filed 2015-03-30
- Panbela Therapeutics, Inc. payments to acquire property, plant, and equipment for the quarter ending 2013-12-31 was $1.61K.
- Panbela Therapeutics, Inc. payments to acquire property, plant, and equipment for the quarter ending 2013-09-30 was $0.00, a 100.00% decline year-over-year.
- Panbela Therapeutics, Inc. payments to acquire property, plant, and equipment for the quarter ending 2012-09-30 was $21.71K.
- Panbela Therapeutics, Inc. payments to acquire property, plant, and equipment for the quarter ending 2012-06-30 was $170.00.
- Panbela Therapeutics, Inc. payments to acquire property, plant, and equipment for fiscal 2013 was $5.12K.
- Panbela Therapeutics, Inc. payments to acquire property, plant, and equipment for fiscal 2011 was $9.53K.
| Period end | Payments to Acquire Property, Plant, and Equipment 3 month | Payments to Acquire Property, Plant, and Equipment 6 month | Payments to Acquire Property, Plant, and Equipment 9 month | Payments to Acquire Property, Plant, and Equipment 12 month |
|---|---|---|---|---|
| 2013-12-31 | $1.61K derived: 10-K 12 month − 10-Q 9 month · filed 2015-03-30 | $1.61K derived: sum of 2 quarters · filed 2015-03-30 | $5.12K 10-K · filed 2015-03-30 | |
| 2013-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2013-11-14 | $3.50K 10-Q · filed 2013-11-14 | ||
| 2013-06-30 | $3.50K 10-Q · filed 2013-08-14 | |||
| 2012-09-30 | $21.71K derived: 10-Q 9 month − 10-Q 6 month · filed 2013-11-14 | $21.88K derived: sum of 2 quarters · filed 2013-11-14 | $2.76K 10-Q · filed 2013-11-14 | |
| 2012-06-30 | $170.00 derived: 10-Q 6 month − 10-Q 3 month · filed 2013-08-14 | -$18.95K 10-Q · filed 2013-08-14 | ||
| 2012-03-31 | -$19.12K 10-Q · filed 2013-05-15 | |||
| 2011-12-31 | $9.53K 10-K · filed 2013-03-26 |